Lung cancer is the leading cause of cancer-related deaths among men and women in the United States, despite being the second most commonly diagnosed cancer.
Anti-PD-1/PD-L1 Immunotherapy in Lung Cancer: Updates From the ESMO 2016 Congress
Advertisement
Advertisement
Trending on OncLive
1
Dr Mesa on the FDA Approval of Ropeginterferon Alfa-2b for Essential Thrombocythemia
2
TTFields Add a New Dimension to the Changing Pancreatic Cancer Treatment Paradigm
3
Zanidatamab Plus Chemotherapy Improves OS at Second Interim Analysis of HERIZON-GEA-01 in First-Line HER2+ GEA
4
Savolitinib Plus Osimertinib Improves First-Line PFS in MET-Overexpressing EGFR-Mutated NSCLC
5